Skip to main content

Adding cisplatin to docetaxel monotherapy provides no benefit for elderly with NSCLC

Primary tabs

View
Get Stamp Tags
Published Locations

Breadcrumb

Home
Adding cisplatin to docetaxel monotherapy provides no benefit for elderly with NSCLC

User login

Username

Password

Reset your password

Type	Lead	score